Ensequence, Inc.
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04N (Pictorial Communication, e.g. Television).
The verdict
According to USPTO PatentsView, Ensequence ranks #35,206 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 3 technology areas.
- #35,206
- of 49,997 US assignees by volume
- 10th percentile
- by Innovation Score (22.1/100)
- 14.7
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R35206 · US Corporation #35,206 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- MID-PACK #35,206/49,997
- PHOTO-FINISH Enginuity Communicat…
- CPC-NARROW H04N · 3 areas
- INNOV-THIN 22.1/100
- CLAIMS-RICH 14.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Enginuity Communications Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ensequence’s 22.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ensequence
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ensequence · this assignee 22
Ensequence · this assignee
22 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ensequence's Innovation Score is 22.1/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ensequence?
Each dot is one of Ensequence’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ensequence’s own 14.7 claims/patent is at or below the 19.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Ensequence's grants concentrate
Ensequence, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 71.4% of grants classified under H04N (Pictorial Communication, e.g. Television). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2017. By volume, Ensequence sits between Enginuity Communications Corp. and Ergon International GmbH.
Who files at Ensequence's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Enginuity Communi…
Enginuity Communications Corp.
7 patents
- Englert
Englert, Inc.
7 patents
- Enopace Biomedical
Enopace Biomedical Ltd.
7 patents
- Enovix Operations
Enovix Operations Inc.
7 patents
- Environ-metal
Environ-Metal, Inc.
7 patents
- Epix Orthopaedics
Epix Orthopaedics, Inc.
7 patents
- Ergo-flex
Ergo-Flex Technologies, LLC
7 patents
- Ergon Internation…
Ergon International GmbH
7 patents
- Ensequence ◀
Ensequence, Inc.
7 patents
What this shows Ensequence holds 7 patents at rank #35,234, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ensequence
By rank, the assignees closest to #35,234 in granted patent volume.
- Enginuity Communications Corp. #35,230 · 7 patents
- Englert, Inc. #35,231 · 7 patents
- Enopace Biomedical Ltd. #35,232 · 7 patents
- Enovix Operations Inc. #35,233 · 7 patents
- Environ-Metal, Inc. #35,235 · 7 patents
- Epix Orthopaedics, Inc. #35,236 · 7 patents
- Ergo-Flex Technologies, LLC #35,237 · 7 patents
- Ergon International GmbH #35,238 · 7 patents
Leaders in H04N (Pictorial Communication)
Other assignees with the most granted patents in Ensequence's primary technology class.
Ensequence's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
22 10th percentile higher than 10% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 42.9% |
| 2016 | 3 | 42.9% |
| 2017 | 1 | 14.3% |
Which technologies does Ensequence, Inc. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ensequence, Inc.'s patent record in context - here's where to go next.
- Ensequence, Inc.'s lead technology class is H04N (Pictorial Communication, e.g. Television), 71.4% of its portfolio - see every assignee active in that class. Explore H04N
- Ranked #35,206 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ensequence, Inc. against Enginuity Communications Corp., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.